Brodalumab efficacy in bio-naïve psoriasis patients: real-life experience of 202 subjects up to 48 weeks. (17th November 2022) - Mastorino, Luca; Cariti, C.; Susca, S.; Boskovic, S.; Aquino, C.; Ortoncelli, M.; Stroppiana, E.; Verrone, A.; Dapavo, P.; Quaglino, P.; Ribero, Simone